Protoporphyrin IX–gold nanoparticle conjugates as an efficient photosensitizer in cervical cancer therapy
- 1 September 2013
- journal article
- research article
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 10 (3) , 304-312
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Porphyrin-photosensitized processes: their applications in the prevention of arterial restenosis.Cardiovascular & Hematological Agents in Medicinal Chemistry, 2007
- Current Clinical and Preclinical Photosensitizers for Use in Photodynamic TherapyJournal of Medicinal Chemistry, 2004
- Photodynamic Therapy for Esophageal Diseases: A Clinical UpdateEndoscopy, 2003
- Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trialBritish Journal of Dermatology, 2001
- Photodynamische Therapie in der PneumologiePneumologie, 2000
- Kinetic fluorescence studies of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation in basal cell carcinomasJournal of Photochemistry and Photobiology B: Biology, 1999
- Photodynamic TherapyJNCI: Journal of the National Cancer Institute, 1998
- Photodynamic therapy of vein grafts: Suppression of intimal hyperplasia of the vein graft but not the anastomosisJournal of Vascular Surgery, 1995
- Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapyChemical Society Reviews, 1995
- On the diffusion length of singlet oxygen in cells and tissuesJournal of Photochemistry and Photobiology B: Biology, 1990